<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS199439</article-id><article-id pub-id-type="doi">10.1101/2024.10.10.617527</article-id><article-id pub-id-type="archive">PPR924103</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">4</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Semi-supervised Omics Factor Analysis (SOFA) disentangles known and latent sources of variation in multi-omic data</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Capraz</surname><given-names>Tümay</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Vöhringer</surname><given-names>Harald</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Serrano</surname><given-names>Klaus Sebastian Augusto Kruger</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Flores</surname><given-names>Ricardo Omar Ramirez</given-names></name><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>Saez-Rodriguez</surname><given-names>Julio</given-names></name><xref ref-type="aff" rid="A6">6</xref><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>Huber</surname><given-names>Wolfgang</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref></contrib></contrib-group><aff id="A1"><label>1</label>Collaboration for joint PhD degree between EMBL and <institution-wrap><institution-id institution-id-type="ror">https://ror.org/038t36y30</institution-id><institution>Heidelberg University</institution></institution-wrap>, Faculty of Biosciences, <city>Heidelberg</city>, <country country="DE">Germany</country></aff><aff id="A2"><label>2</label>Genome Biology Unit, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/03mstc592</institution-id><institution>EMBL</institution></institution-wrap>, <city>Heidelberg</city>, <country country="DE">Germany</country></aff><aff id="A3"><label>3</label>Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany</aff><aff id="A4"><label>4</label>Department of Medicine V, Hematology, Oncology and Rheumatology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/013czdx64</institution-id><institution>University Hospital Heidelberg</institution></institution-wrap>, <city>Heidelberg</city>, <country country="DE">Germany</country></aff><aff id="A5"><label>5</label>Department of Hematology and Oncology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/006k2kk72</institution-id><institution>University Hospital Düsseldorf</institution></institution-wrap>, <city>Düsseldorf</city>, <country country="DE">Germany</country></aff><aff id="A6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/038t36y30</institution-id><institution>Heidelberg University</institution></institution-wrap>, Faculty of Medicine, and <institution-wrap><institution-id institution-id-type="ror">https://ror.org/013czdx64</institution-id><institution>Heidelberg University Hospital</institution></institution-wrap>, Institute for Computational Biomedicine, <city>Heidelberg</city>, <country country="DE">Germany</country></aff><aff id="A7"><label>7</label>European Molecular Biology Laboratory, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/02catss52</institution-id><institution>European Bioinformatics Institute (EMBL-EBI)</institution></institution-wrap>, <city>Hinxton, Cambridgeshire</city>, <country country="GB">U.K</country></aff><author-notes><corresp id="CR1">Correspondence, Tümay Capraz, EMBL Heidelberg, Meyhofer Str. 1, 69117 Heidelberg, <email>tuemay.capraz@embl.de</email>
</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>16</day><month>10</month><year>2024</year></pub-date><pub-date pub-type="preprint"><day>14</day><month>10</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">CC BY-NC 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">A fundamental design pattern in biomolecular studies is to assay the same set of samples (organisms, tissue biopsies, or individual cells) by multiple different ‘omics assays. Group Factor Analysis (GFA) and its adaptation to high-dimensional settings, Multi-Omics Factor Analysis (MOFA), are widely used as a first-line approach to analyse such data and are effective in detecting patterns of correlation, organize them into so-called latent factors, and identify common and assay-specific factors. However, in many applications a subset of the found factors just rediscovers already known covariates (e.g., disease subtypes, environmental covariates) while others may represent genuine novelty.</p><p id="P2">Here, we present Semi-supervised Omics Factor Analysis (SOFA), a method that incorporates known covariates into the model upfront and focuses the factor discovery on novel sources of variation. We show SOFA’s effectiveness for discovering novel patterns by applying it to cancer, brain development and heart failure multi-omic data sets.</p></abstract></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P3">Using multiple “omic” measurement technologies on the same large set of biological specimens or samples is a fundamental design principle for studying biological variation<sup><xref ref-type="bibr" rid="R1">1</xref>–<xref ref-type="bibr" rid="R4">4</xref></sup>. With thousands or millions of features measured, the manifold hypothesis posits that the data concentrate along an (unknown) low-dimensional manifold inside the high-dimensional data space. Biological variation then corresponds to different positions on that manifold. Empirically, it has been found that useful coordinates on that manifold—what we might call interesting axes of biological variation—can be constructed by linear summary statistics. For instance, in principal component analysis (PCA) or its extension to factor analysis, each principal axis, or factor, is a linear combination of features, and this (weighted) averaging has the effect of reducing noise compared to looking at variation only by measuring individual features. Since typically a relatively small number of top principal axes or factors is considered, such approaches may also be viewed as dimension reduction techniques.</p><p id="P4">To take into account the multimodal structure of data, there are extensions of these methods including canonical correlation analysis (CCA)<sup><xref ref-type="bibr" rid="R5">5</xref></sup>, group factor analysis (GFA)<sup><xref ref-type="bibr" rid="R6">6</xref></sup>, multi-omics factor analysis (MOFA)<sup><xref ref-type="bibr" rid="R7">7</xref></sup>, iCLuster<sup><xref ref-type="bibr" rid="R8">8</xref></sup>, and MuVI<sup><xref ref-type="bibr" rid="R9">9</xref></sup>.</p><p id="P5">Applied to data, these methods return factors that, typically, fall into two categories: unsurprising and surprising. Unsurprising factors include those that align to known covariates (e.g., in the case of tissue biopsies, disease diagnosis, age or sex of the patient; in the case of environmental samples, geographical sampling location), or to technical artefacts<sup><xref ref-type="bibr" rid="R10">10</xref></sup> (batch effects) associated with known experimental metadata. Surprising factors have no such easily identifiable explanation and are candidates for scientific novelty. The above-mentioned methods are unsupervised, in the sense that they do not use such already known information, and users are required to make their surprisingness considerations post-hoc<sup><xref ref-type="bibr" rid="R11">11</xref></sup>, in a process that is informal and error-prone.</p><p id="P6">Here, we present Semi-supervised Omics Factor Analysis (SOFA), a probabilistic factor model that jointly models multi-modal omics data and sample-level information (hereafter: guiding variables). SOFA approximates the data with a low-rank matrix decomposition and partitions the latent factors into guided factors each associated with a guiding variable, and unguided factors. In this way, already expected biological and technical drivers of variation can be regressed out from the latent space, making the interpretation of the remaining “surprising” factors simpler and potentially more fruitful.</p><p id="P7">Our model takes inspiration from prior work in the unimodal setting. Principal component regression (PCR) uses PCA factors as covariates in a regression model to predict guiding variables<sup><xref ref-type="bibr" rid="R12">12</xref></sup>. However, PCR does not guarantee that its covariates are relevant, since for their construction it only considers their covariance structure, but not the guiding variables. Partial least squares (PLS) simultaneously decomposes a high-dimensional set of predictors and guiding variables, aiming to find factors that capture the maximum covariance between the two<sup><xref ref-type="bibr" rid="R13">13</xref>,<xref ref-type="bibr" rid="R14">14</xref></sup>. SPEAR<sup><xref ref-type="bibr" rid="R15">15</xref></sup> and DIABLO<sup><xref ref-type="bibr" rid="R16">16</xref></sup> enable the incorporation of guiding variables of interest in the multimodal setting. Like PLS, these methods primarily uncover “unsurprising” factors that align with the guiding variables, rather than explicitly identifying “surprising” or unexpected factors.</p><p id="P8">We present four applications of SOFA that highlight its broad utility: to the pan-gynecologic cohort of The Cancer Genome Atlas (TCGA)<sup><xref ref-type="bibr" rid="R17">17</xref></sup>, to the cancer dependency map<sup><xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R19">19</xref></sup> (DepMap), to single-cell multi-omic data of microglial cells<sup><xref ref-type="bibr" rid="R20">20</xref></sup>, and to a collection of data sets of acute and chronic human heart failure <sup><xref ref-type="bibr" rid="R21">21</xref>–<xref ref-type="bibr" rid="R26">26</xref></sup>. We provide the SOFA method as an open source Python package along with comprehensive tutorials.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>The SOFA Model</title><p id="P9">The input to SOFA is a set of numeric data matrices containing multi-omic measurements from the same or mostly overlapping samples, and one or more covariates for each sample. The covariates can be continuous, binary or categorical and contain information that is known or suspected to be important for driving biological or technical variation between the samples. We also call these covariates <italic>sample-level guiding variables</italic>, and the different types of omics data <italic>views</italic>. From this input, SOFA extracts a lower-dimensional representation comprising a shared factor matrix and modality-specific loading matrices (<xref ref-type="fig" rid="F1">Fig. 1a</xref>). SOFA partitions the latent factors into guided factors each associated with a guiding variable, and unguided factors (<xref ref-type="fig" rid="F1">Fig. 1b</xref>). The loading weights of each factor represent, for each view, the molecular features that it depends on, and can usually be interpreted in terms of biological processes, gene expression programmes, modes of regulation, and the like (<xref ref-type="sec" rid="S9">Methods</xref>, <xref ref-type="fig" rid="F1">Fig. 1c</xref>). The factor matrix positions each sample in the latent space spanned by the factors, and each sample’s coordinates along the various factors can be interpreted as a degree of activity of a factor in the sample, similarly as in PCA or MOFA.</p><p id="P10">SOFA is a hierarchical Bayesian factor model, and we ensured scalability of its inference to large multi-omic data sets by employing stochastic variational inference (<xref ref-type="sec" rid="S9">Methods</xref>). Our inference method for SOFA employs a sparsity inducing prior<sup><xref ref-type="bibr" rid="R27">27</xref></sup>, which pulls the loading weights of some factors for some modalities to zero, if the data are not pulling them elsewhere strongly enough. As a result, we can distinguish between variation that is commonly shared across modalities and variation that is present in only one or a few modalities.</p></sec><sec id="S4"><title>SOFA identifies cancer type independent immune infiltration vs proliferation axis in the TCGA pan-gynecologic data set</title><p id="P11">We applied SOFA to a pan-gynecologic cancer multi-omic data set of the cancer genome atlas (TCGA) project, which profiled the transcriptome (mRNA), proteome, methylome, and miRNA of 2599 samples from five different cancers<sup><xref ref-type="bibr" rid="R17">17</xref>,<xref ref-type="bibr" rid="R28">28</xref>–<xref ref-type="bibr" rid="R31">31</xref></sup>. Additionally, the study includes data about mutations, metadata, and clinical endpoints progression free interval (PFI) and overall survival (OS).</p><p id="P12">We performed a SOFA rank-12 decomposition, using five guided factors with binary labels for each cancer type and seven unguided factors. Guided factors showed a clear separation based on the binary cancer type labels (<xref ref-type="fig" rid="F2">Fig. 2a</xref>). We then verified that the unguided factors did not capture cancer type-related variance by computing Adjusted Rand Index (ARI) scores to assess clustering alignment with cancer labels (<xref ref-type="supplementary-material" rid="SD2">Fig S2e</xref>, <xref ref-type="sec" rid="S9">Methods</xref>). This analysis showed that the set of unguided factors had the lowest alignment with cancer type labels, suggesting that the guided factors mostly explained the cancer-associated variability. Of note, ARI scores for the unguided SOFA decompositions at both rank-7 and rank-12 exhibited lower cluster alignment in comparison to the guided factorisation, indicating that factor guidance helped disentangle cancer-associated variability (<xref ref-type="supplementary-material" rid="SD2">Fig. S2a,c,e</xref>).</p><p id="P13">To evaluate the importance of each factor, we calculated the fraction of variance explained by each factor across the input modalities (<xref ref-type="fig" rid="F2">Fig. 2b</xref>). For example, Factor 3 explained the highest fraction of variance in the miRNA data, consistent with previous research suggesting miRNA expression is critical in ovarian cancers and may serve as a biomarker<sup><xref ref-type="bibr" rid="R32">32</xref>,<xref ref-type="bibr" rid="R33">33</xref></sup>. Factor 1, representative for breast cancers, showed breast cancer associated proteins AR<sup><xref ref-type="bibr" rid="R34">34</xref></sup>, PR<sup><xref ref-type="bibr" rid="R35">35</xref></sup> and ER-alpha<sup><xref ref-type="bibr" rid="R36">36</xref></sup> among the largest proteomics loading weights (<xref ref-type="supplementary-material" rid="SD2">Fig. S2f</xref>). Factor 3 (ovarian serous cystadenocarcinoma) featured <italic>BCAM</italic><sup><xref ref-type="bibr" rid="R37">37</xref></sup>, <italic>MALAT1</italic><sup><xref ref-type="bibr" rid="R38">38</xref></sup> <italic>and WT1</italic><sup><xref ref-type="bibr" rid="R39">39</xref></sup> among the highest transcriptomics loadings weights (<xref ref-type="supplementary-material" rid="SD2">Fig. S2g</xref>).</p><p id="P14">We then explored the SOFA factors for potential biological relevance by testing them for association with disease outcome, using univariate Cox regression of each factor on overall survival (OS, <xref ref-type="fig" rid="F2">Fig 2b</xref>). Notably, Factor 3, linked to ovarian serous cystadenocarcinoma, was significantly linked to poor survival (Hazard Ratio (HR)=2.44 95% CI: 2.17-2.75). Two out of seven unguided factors showed significant associations with OS, suggesting that most of these factors do not strongly influence survival outcomes. Among the unguided factors predictive of survival, we further investigated Factor 10, which had the highest HR among the unguided Factors (HR=1.56 95% CI: 1.25-1.94, <xref ref-type="fig" rid="F2">Fig. 2b</xref>). Stratifying samples by Factor 10 values, followed by non-parametric survival curve estimation, revealed substantial differences in median survival times between groups (OS: Median survival time 1701 vs. 2888 days, PFI: 1396 vs 3669 days, <xref ref-type="fig" rid="F2">Fig. 2c</xref>). Negative loadings of Factor 10 featured <italic>NTN4, CD59</italic> and <italic>CFB</italic>, and proteins including PDCD4, indicative of complement system activation and lymphocyte infiltration<sup><xref ref-type="bibr" rid="R40">40</xref>–<xref ref-type="bibr" rid="R43">43</xref></sup>(<xref ref-type="fig" rid="F2">Fig. 2d</xref>). In contrast, positive loadings included proliferation markers <italic>TOP2A</italic> and <italic>TPX2</italic>, as well as Cyclin B1, FoxM1<sup><xref ref-type="bibr" rid="R44">44</xref>–<xref ref-type="bibr" rid="R47">47</xref></sup>, suggesting a signature of increased proliferation. This was further corroborated by performing a gene set overrepresentation analysis on the top transcriptomics loadings. Negative loadings were associated with immune system related gene sets, while those with positive loadings were enriched in cell cycle and proliferation related terms (<xref ref-type="fig" rid="F2">Fig. 2e</xref>). Finally, we note that Factor 10 was not restricted to a single cancer type (<xref ref-type="supplementary-material" rid="SD2">Fig. S2b,d</xref>), indicating that it captured biological signatures common to all cancers. Taken together, we found that the guided SOFA factorization delineated cancer type-specific variation from broader biological processes, such cell proliferation or immune cell infiltration, thereby facilitating their identification and subsequent downstream analyses.</p></sec><sec id="S5"><title>SOFA identifies EGFR dependency axis in pan-cancer dependency map, while accounting for known driver mutations and cell growth</title><p id="P15">Next, we analyzed a pan-cancer cell line data set of the Cancer Dependency Map (DepMap)<sup><xref ref-type="bibr" rid="R19">19</xref>,<xref ref-type="bibr" rid="R48">48</xref></sup> together with proteomics data from the ProCan-DepMapSanger study<sup><xref ref-type="bibr" rid="R18">18</xref></sup>. The DepMap project aims to identify cancer vulnerabilities and drug targets across a diverse range of cancer types. The data set includes multi-omic data, encompassing transcriptomics<sup><xref ref-type="bibr" rid="R49">49</xref></sup>, proteomics<sup><xref ref-type="bibr" rid="R18">18</xref></sup>, and methylation<sup><xref ref-type="bibr" rid="R50">50</xref></sup>, as well as drug response profiles for 627 drugs<sup><xref ref-type="bibr" rid="R50">50</xref></sup>, and CRISPR-Cas9 gene essentiality scores<sup><xref ref-type="bibr" rid="R48">48</xref></sup> for 17,485 genes for 949 cancer cell lines across 26 different tissues.</p><p id="P16">To identify CRISPR-Cas9 gene essentiality scores associated with multi-omic features, we performed a rank-20 SOFA decomposition to the DepMap data, while accounting for potential/known drivers of variation such as growth rate, microsatellite instability (MSI) status, <italic>BRAF, TP53</italic> and <italic>PIK3CA</italic> mutation and hematopoietic lineage. Although CRISPR-Cas9 essentiality scores could technically be included as an additional view in the SOFA decomposition, we chose to exclude them to enable independent testing of factor associations with these scores.</p><p id="P17">A t-SNE of all the inferred factors showed that they captured the differences between cancer types (<xref ref-type="fig" rid="F3">Fig. 3a</xref>). Further, we confirmed successful factor guidance by asserting that SOFA extracted high or low factor values in a variable-dependent manner (<xref ref-type="fig" rid="F3">Fig. 3c</xref>). We then focused on the guided factors and observed that Factor 6, consistent with previous studies identifying hematopoietic lineage as a major driver of variation in cell lines<sup><xref ref-type="bibr" rid="R18">18</xref></sup>, explained the largest fraction of variance (34%) across all data modalities (<xref ref-type="fig" rid="F3">Fig. 3b</xref>). Factor 1, guided by growth rate, mostly explained variance in drug response (<xref ref-type="fig" rid="F3">Fig. 3b</xref>), which is expected as the natural logarithm of the half maximal inhibitory concentration (lnIC50) drug response is derived from the growth rate of the cell line. We then subjected the loadings of guided factors to gene set overrepresentation analysis. Expectedly, Factor 3, guided with labels for BRAF mutation, a common mutation in skin cancer<sup><xref ref-type="bibr" rid="R51">51</xref></sup>, was associated with skin cancer related gene sets (<xref ref-type="supplementary-material" rid="SD2">Fig. S3c</xref>). The loadings of Factor 6, guided with hematopoietic lineage, displayed gene sets related to the immune system (<xref ref-type="supplementary-material" rid="SD2">Fig. S3d</xref>). Statistical testing revealed that Factors 3 and 4 were significantly associated with CRISPR-Cas9 essentiality scores of BRAF and TP53, the mutations used to guide these factors (<xref ref-type="supplementary-material" rid="SD2">Fig. S3e-f</xref>, <xref ref-type="sec" rid="S9">Methods</xref>).</p><p id="P18">Among the unguided factors, Factor 10 had the highest values in colorectal and lung cancer cell lines (<xref ref-type="supplementary-material" rid="SD2">Fig. S3a</xref>). A closer examination revealed that this factor delineated non-small cell lung cancer (NSCLC) from small cell lung cancer (SCLC) (<xref ref-type="fig" rid="F3">Fig. 3d</xref>). Top-ranking genes featured regulators of the epidermal growth factor receptor (EGFR), including <italic>LCN2, AREG, LAMC2, TNS4</italic> and <italic>KRT16</italic><sup><xref ref-type="bibr" rid="R52">52</xref>–<xref ref-type="bibr" rid="R56">56</xref></sup> (<xref ref-type="fig" rid="F3">Fig. 3e</xref>). Similarly, the lowest loadings for drug response lnIC50 values, indicating sensitivity, were EGFR targeting drugs Gefitinib, Afatinib and Sapatinib (<xref ref-type="fig" rid="F3">Fig. 3e</xref>). To confirm the association between the EGFR pathway and Factor 10, we tested for associations with CRISPR-Cas9 essentiality scores, indeed EGFR was a top ranking association (<xref ref-type="fig" rid="F3">Fig. 3f</xref>). Further, high Factor 10 values were associated with cell lines harboring <italic>EGFR, TP53, APC, SMAD</italic> and <italic>KRAS</italic> mutations, which were previously described to play a role in progression of colorectal cancer<sup><xref ref-type="bibr" rid="R57">57</xref>,<xref ref-type="bibr" rid="R58">58</xref></sup> (<xref ref-type="fig" rid="F3">Fig. 3h</xref>).</p><p id="P19">Factor 12 separated B cells, T cells, and myeloid cells within the hematopoietic lineage (<xref ref-type="fig" rid="F3">Fig. 3g</xref> and <xref ref-type="supplementary-material" rid="SD2">S3b</xref>). Correlating Factor 12 with CRISPR-Cas9 essentiality scores showed that positive factor values (B-cells) were significantly associated with B-cell markers <italic>EBF1, PAX5</italic> and <italic>MEF2B</italic><sup><xref ref-type="bibr" rid="R59">59</xref>,<xref ref-type="bibr" rid="R60">60</xref></sup>, while negative values (myeloid cells) were significantly linked to myeloid markers <italic>MYB</italic> and <italic>CBFB</italic><sup><xref ref-type="bibr" rid="R61">61</xref>,<xref ref-type="bibr" rid="R62">62</xref></sup> (<xref ref-type="fig" rid="F3">Fig. 3i</xref>). In summary, by leveraging multi-omic data together with CRISPR-Cas9 essentiality scores, we identified an unguided factor linked to the EGFR pathway, along with another factor that explained the difference between hematopoietic cell types.</p></sec><sec id="S6"><title>SOFA disentangles between and within cell type variation in a single-cell multi-omic data set of the human developing cerebral cortex</title><p id="P20">We applied SOFA to infer 15 factors from data of a single-cell multi-omic experiment<sup><xref ref-type="bibr" rid="R20">20</xref></sup>, where the authors simultaneously profiled the transcriptome (RNA) and chromatin accessibility (ATAC) of 45,549 single cells of the human cerebral cortex at six different developmental stages. The authors identified 13 different cell types in the data.</p><p id="P21">We assumed that guiding a subset of SOFA factors with cell type labels could help reveal variations within cell types through the unguided factors. To test this, we conducted a rank-15 SOFA decomposition on the single-cell multi-omic data set, guiding the first 13 factors with binary cell type labels while leaving the remaining two factors unguided to capture sources of variation within cell types.</p><p id="P22"><xref ref-type="fig" rid="F4">Fig. 4a</xref> shows the fraction of variance that each factor explained in the RNA and ATAC modalities, with factors guided by microglial and oligodendrocyte labels explaining most variance. The UMAP embedding of all factors in <xref ref-type="fig" rid="F4">Fig. 4b</xref> showed that the cells cluster by cell type clearly separating the different cell types.</p><p id="P23">First, we checked whether the loadings of the guided factors picked up biological signals related to their guiding covariate. Indeed, the guided factors separated cells based on their guiding cell type labels (<xref ref-type="supplementary-material" rid="SD2">Fig. S4a</xref>). The top loadings of the guided factors were cell type specific markers of their respective guiding cell type label. Highest transcriptomics loadings of Factor 1 (astrocytes) included astrocyte specific marker genes such as <italic>SLC1A2</italic>, SLC1A3<sup><xref ref-type="bibr" rid="R63">63</xref></sup> and <italic>GLUL</italic><sup><xref ref-type="bibr" rid="R64">64</xref></sup>. Factor 7 (microglial cells) captured microglia markers <italic>CSF1R</italic><sup><xref ref-type="bibr" rid="R65">65</xref></sup>, <italic>TYROBP</italic><sup><xref ref-type="bibr" rid="R66">66</xref></sup> and <italic>CX3CR1</italic><sup><xref ref-type="bibr" rid="R67">67</xref></sup>. Factor 9 (oligodendrocytes) had <italic>MBP</italic><sup><xref ref-type="bibr" rid="R68">68</xref></sup>, <italic>MOBP</italic><sup><xref ref-type="bibr" rid="R69">69</xref></sup> and <italic>PLP1</italic><sup><xref ref-type="bibr" rid="R70">70</xref></sup> among the top transcriptomics loadings.(<xref ref-type="supplementary-material" rid="SD2">Fig. S4b-d</xref>).</p><p id="P24">When further inspecting the unguided factors, we found that Factor 14 captured variation within microglial cells and was only active in a subset of microglial cells with relatively high and low factor values (<xref ref-type="fig" rid="F4">Fig. 4c</xref>). Gene set overrepresentation analysis on the transcriptomics and ATAC loadings of Factor 14, revealed that the positive loadings are related to microglial migration and transport processes, while the negative loadings play a role in inflammatory response and interleukin signaling (<xref ref-type="fig" rid="F4">Fig. 4e and 4f</xref>). Previous studies using single-cell RNA-seq data from microglia indicated that there is a diverse range of microglial subtypes<sup><xref ref-type="bibr" rid="R71">71</xref></sup>, including populations expressing genes related to inflammatory response<sup><xref ref-type="bibr" rid="R72">72</xref></sup> and migration<sup><xref ref-type="bibr" rid="R71">71</xref></sup>. Furthermore, microglia play a critical role in brain development<sup><xref ref-type="bibr" rid="R73">73</xref></sup>, especially during adolescence<sup><xref ref-type="bibr" rid="R74">74</xref></sup> and Factor 14 was mostly active in cells from the adolescence age group (<xref ref-type="fig" rid="F4">Fig. 4c-d</xref>).</p><p id="P25">This shows that SOFA is also capable of finding biologically interesting patterns, such as within cell type variation, in single-cell multi-omic data sets.</p></sec><sec id="S7"><title>Comparison of SOFA and MOFA in the analysis of heart failure single-cell data</title><p id="P26">We compared SOFA’s guided factor analysis approach to MOFA’s unsupervised one to evaluate whether SOFA enhances detection of covariate-associated low variance signals, while preserving the integrity of factors representing dominant variability. We applied both methods in the context of multicellular integration of single-cell RNA-Seq data, that aims at inferring coordinated gene expression programs between cell-types in tissues, across a previously curated collection of five datasets of acute and chronic human heart failure <sup><xref ref-type="bibr" rid="R21">21</xref>–<xref ref-type="bibr" rid="R26">26</xref></sup>. This collection of data sets includes single-cell RNA-Seq data of seven cell types from chronic human heart failure cases (HF) and controls (NF), along with covariates including age, sex, and heart failure status, a binary variable indicating patients with any heart disease etiology that required heart transplantation (<xref ref-type="supplementary-material" rid="SD2">Fig. S5a-b</xref>). To apply SOFA and MOFA, we pseudo bulked the gene expression of each cell type and represented them as separate views (<xref ref-type="supplementary-material" rid="SD2">Fig. S5c</xref>). This enables the inferred factors to capture gene expression coordination across cell types—referred to as multicellular programs—which could then be associated with patient-level covariates. Heart failure was expected to be the primary source of variability in these data sets<sup><xref ref-type="bibr" rid="R21">21</xref></sup>. However, given the smaller cohort sizes compared to our previous analysis examples (maximum size = 79), low variance covariates like age and sex might be challenging to detect using an unsupervised model. We fitted a MOFA model and two SOFA models: one guided by age and sex, and another that included guidance from both age and sex along with heart failure binary status. This approach allowed us to assess whether SOFA could identify factors associated with less dominant covariates and evaluate the impact of factor guidance on the detection of unguided factors representing major sources of variability, in this case heart failure. We observed that both methods recovered a comparable fraction of variance associated with heart failure and age. However, SOFA models recovered a greater fraction of variance (mean=3.65% SOFA HF guided; mean=3.7% SOFA HF unguided) associated with sex across data sets compared to MOFA (mean=0.43%), which showed near-zero values in all but one data set (<xref ref-type="supplementary-material" rid="SD2">Fig. S5d</xref>). To assess whether guiding SOFA with known covariates would hamper the unguided factors to capture the main sources of variability — here heart failure —, we correlated the heart failure-associated factors between the MOFA model and the SOFA model not guided with heart failure. The mean Spearman correlation of 0.81 and 0.870 at both the factor score and gene loading levels indicated minimal influence of factor guidance on these unguided factors. Next, we evaluated whether the loadings of the heart failure and sex-associated factors across the three models captured similar results as the ones expected from differential expression analyses. First, we used DEseq2 models to identify differentially expressed genes between failing and non-failing hearts, and males and females, across cell-types for each data set independently (adj. P-value &lt; 0.05). Then we sampled an identical number of genes from the gene loadings ranked by their absolute value. We observed higher recall for heart failure of the SOFA model guided with heart failure (mean=66.2%) compared to the other two models (mean=55.05% SOFA HF unguided; mean=55.25% MOFA) (<xref ref-type="supplementary-material" rid="SD2">Fig. S5e</xref>). For the sex-associated factors we observed a mean recall of 55.84% in the SOFA models. Together, these results highlight that guided SOFA factors can enhance the detection of gene expression profiles associated with low variance covariates like sex while preserving the ability to infer major sources of variability, providing a flexible alternative to fully unsupervised models.</p></sec></sec><sec id="S8" sec-type="discussion"><title>Discussion</title><p id="P27">SOFA is a fully interpretable probabilistic framework for the analysis of multi-omic data.</p><p id="P28">It is based on group factor analysis methods such as GFA and MOFA<sup><xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R7">7</xref></sup> and decomposes multi-omic data into latent factors that capture shared or modality-specific variance across multiple omics modalities. In contrast to existing latent factor models, it enables the incorporation of a priori known (or suspected) drivers of variation. The drivers of variation can be covariates such as mutations, pathways, cancer or cell types. While the guided factors explain variation in the molecular omics data that is driven by the guiding variables, the unguided factors can capture the remaining variation, potentially leading to novel biological insights.</p><p id="P29">Previously reported analysis approaches to such data either involved manual post-hoc annotation of factors, or splitting of the data into subsets of cell types, tissues etc., to identify subset specific factors<sup><xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R21">21</xref>,<xref ref-type="bibr" rid="R75">75</xref></sup>. SOFA offers a potentially easier and more straightforward workflow, by employing the complete data and the guiding variables in a single end-to-end analysis.</p><p id="P30">The versatility of SOFA was showcased through four examples of exploratory data analysis. Analysis of the pan-gynecologic cohort of the TCGA<sup><xref ref-type="bibr" rid="R17">17</xref></sup> revealed a biological stratification predictive of survival and independent of cancer type. In a second example, we identified a latent factor related to EGFR cancer dependency enriched in lung and colorectal cancer samples in a pan-cancer cell line analysis of the DepMap<sup><xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R19">19</xref></sup>. Applying SOFA to a single-cell multi-omic data set from cells of the developing human cerebral cortex<sup><xref ref-type="bibr" rid="R20">20</xref></sup>, we show that SOFA can account for inter cell type heterogeneity, while discovering factors explaining intra cell type heterogeneity. We compared SOFA and MOFA, a method that does not offer the ability to guide factors with known covariates, in an integrative analysis of five data sets of acute and chronic human heart failure</p><p id="P31">SOFA is a tool for exploratory analysis of multi-omic data sets. It identifies sets of features (e.g., representing genes and gene products) that covary across multiple modalities. It is aimed to generate hypotheses that will be validated with independent test data or follow-up experiments. SOFA is a linear method, which facilitates interpretation, but would be a limitation if there are important phenomena that are only evident through non-linear functions of the features. The current implementation of SOFA considers each omics view with a Gaussian likelihood. For highly heteroskedastic data, such as, for instance, RNA-seq, appropriate preprocessing and transformation is required.</p><p id="P32">In summary, SOFA is able to discover novel axes of variation while accounting for previously known variation. It is implemented using the probabilistic programming framework Pyro<sup><xref ref-type="bibr" rid="R76">76</xref></sup>, is available as a Python package including documentation and analysis examples, and its processing speed makes it amenable to interactive analysis on data sets such those shown here.</p></sec><sec id="S9" sec-type="methods"><title>Methods</title><sec id="S10"><title>The SOFA model</title><p id="P33">SOFA jointly decomposes a multimodal data set <inline-formula><mml:math id="M1"><mml:mrow><mml:msup><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>X</mml:mi></mml:mstyle><mml:mi>m</mml:mi></mml:msup><mml:mo>∈</mml:mo><mml:msup><mml:mi>ℝ</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mo>×</mml:mo><mml:msup><mml:mi>D</mml:mi><mml:mi>m</mml:mi></mml:msup></mml:mrow></mml:msup></mml:mrow></mml:math></inline-formula> with <italic>m</italic> = 1,…, <italic>M</italic> modalities for <italic>i</italic> = 1 … <italic>N</italic> samples and <italic>j</italic> = 1, …, <italic>D</italic><sup><italic>m</italic></sup> features, and a set of continuous or categorical sample-level covariates (hereafter guiding variables) <bold>Y</bold><sup><xref ref-type="bibr" rid="R1">1</xref></sup>, …, <bold>Y</bold><sup><italic>C</italic></sup> where <bold>Y</bold><sup><italic>c</italic></sup> ∈ ℝ<sup><italic>N</italic></sup> or <inline-formula><mml:math id="M2"><mml:mrow><mml:msup><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>Y</mml:mi></mml:mstyle><mml:mi>c</mml:mi></mml:msup><mml:mo>∈</mml:mo><mml:msubsup><mml:mi>ℕ</mml:mi><mml:mn>0</mml:mn><mml:mi>N</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> with <italic>c</italic> = 1, …, <italic>C</italic> guiding variables into a lower dimensional shared latent factor matrix and modality specific loading matrices. We model the entries <inline-formula><mml:math id="M3"><mml:mrow><mml:msubsup><mml:mi>x</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> of X<sup><italic>m</italic></sup> as normally distributed, given an unobserved mean expression level <italic>μ</italic><sub><italic>ij</italic></sub> and a feature-specific scale parameter <inline-formula><mml:math id="M4"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>j</mml:mi><mml:mi>m</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula>, and the entries <inline-formula><mml:math id="M5"><mml:mrow><mml:msubsup><mml:mi>y</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> of Y<sup><italic>c</italic></sup> with a mean/location parameter <inline-formula><mml:math id="M6"><mml:mrow><mml:msubsup><mml:mi>ν</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> and an optional scale parameter <italic>κ</italic><sup><italic>c</italic></sup> <disp-formula id="FD1"><mml:math id="M7"><mml:mrow><mml:msubsup><mml:mi>x</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msubsup><mml:mo>∼</mml:mo><mml:mi mathvariant="script">N</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msubsup><mml:mi>μ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>j</mml:mi><mml:mi>m</mml:mi></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mspace width="0.2em"/><mml:mtext mathvariant="bold">and</mml:mtext><mml:mspace width="0.2em"/><mml:msubsup><mml:mi>y</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi></mml:msubsup><mml:mo>∼</mml:mo><mml:msup><mml:mi>p</mml:mi><mml:mi>c</mml:mi></mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msubsup><mml:mi>ν</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi></mml:msubsup><mml:mo>,</mml:mo><mml:msup><mml:mi>κ</mml:mi><mml:mi>c</mml:mi></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula> where <italic>P</italic><sup><italic>c</italic></sup> denotes an appropriate likelihood (i.e. Bernoulli, Categorical or Normal) for the <italic>c</italic>’th guiding variable. In SOFA we express <inline-formula><mml:math id="M8"><mml:mrow><mml:msubsup><mml:mi>μ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M9"><mml:mrow><mml:msubsup><mml:mi>ν</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> <disp-formula id="FD2"><mml:math id="M10"><mml:mrow><mml:msubsup><mml:mi>μ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:msubsup><mml:mstyle displaystyle="true"><mml:mo>Σ</mml:mo></mml:mstyle><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>K</mml:mi></mml:msubsup><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mi>w</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msubsup><mml:mspace width="0.2em"/><mml:mtext mathvariant="bold">and</mml:mtext><mml:mspace width="0.2em"/><mml:msubsup><mml:mi>ν</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula> where <inline-formula><mml:math id="M11"><mml:mrow><mml:msubsup><mml:mi>w</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> represents the entries of the <italic>m</italic>th loading weight matrix <inline-formula><mml:math id="M12"><mml:mrow><mml:msup><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>W</mml:mi></mml:mstyle><mml:mi>m</mml:mi></mml:msup><mml:mo>∈</mml:mo><mml:msup><mml:mi>ℝ</mml:mi><mml:mrow><mml:mi>K</mml:mi><mml:mo>×</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mi>m</mml:mi></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:math></inline-formula> consisting of <italic>k</italic> = 1, …, <italic>K</italic> components where, <italic>C</italic> ≤ <italic>K</italic> ≤ min(<italic>D</italic><sub>1</sub>, …, <italic>D</italic><sub><italic>M</italic></sub>), <italic>z</italic><sub><italic>ik</italic></sub> the elements of a factor weight matrix <bold>Z</bold> ∈ ℝ<sup><italic>N</italic> × <italic>K</italic></sup> containing the coordinates of each sample with respect to <bold>W</bold><sup><italic>m</italic></sup>, <italic>α</italic><sub><italic>c</italic></sub> and <italic>β</italic><sub><italic>c</italic></sub> an offset and slope parameter and <italic>g</italic><sub><italic>c</italic></sub> an appropriate inverse link function for the <italic>c</italic>’th guiding variable.</p><p id="P34">SOFA is formulated as a Bayesian probabilistic model and uses prior distributions on the model parameters (for a complete derivation of the model see the <xref ref-type="supplementary-material" rid="SD1">Supplementary Methods</xref>).</p></sec><sec id="S11"><title>Interpretation of the factors</title><p id="P35">Analogous to the interpretation of factors in PCA, SOFA factors ordinate samples along a zero-centered axis, where samples with opposing signs exhibit contrasting phenotypes along the inferred axis of variation, and the absolute value of the factor indicates the strength of the phenotype. Importantly, SOFA partitions the factors of the low-rank decomposition into guided and unguided factors: the guided factors are linked to specific guiding variables, while the unguided factors capture global, yet unexplained, sources of variability in the data.</p></sec><sec id="S12"><title>Interpretation of the loading weights</title><p id="P36">SOFA’s loading weights indicate the importance of each feature for its respective factor, thereby enabling the interpretation of SOFA factors. Loading weights close to zero indicate that a feature has little to no importance for the respective factor, while large magnitudes suggest strong relevance. The sign of the loading weight aligns with its corresponding factor, meaning that positive loading weights indicate higher feature levels in samples with positive factor values, and negative loading weights indicate higher feature levels in samples with negative factor values.</p></sec><sec id="S13"><title>Parameter inference</title><p id="P37">SOFA is formulated as a Bayesian probabilistic model and uses black box variational inference<sup><xref ref-type="bibr" rid="R77">77</xref></sup> to infer the unobserved parameters. Black box variational inference uses a simpler variational distribution to approximate the intractable posterior. It is a scalable technique that uses stochastic optimization to optimize the evidence lower bound (ELBO) with respect to the variational parameters of the variational distribution. The ELBO is optimized using stochastic variational inference by taking Monte Carlo samples from the variational distribution and computing unbiased but noisy gradients with respect to the variational parameters from the ELBO<sup><xref ref-type="bibr" rid="R77">77</xref>,<xref ref-type="bibr" rid="R78">78</xref></sup>. The ELBO can be used to assess convergence.</p><p id="P38">For the implementation of SOFA we used the probabilistic programming framework Pyro<sup><xref ref-type="bibr" rid="R76">76</xref></sup>. If necessary, e.g. for single-cell data, we compute the gradients over subsamples of batches of the observations.</p></sec><sec id="S14"><title>Model selection</title><p id="P39">The number of factors is an important hyperparameter of SOFA that needs to be determined by running the inference multiple times with a varying number of factors. Factors typically become correlated if the decomposition rank is too high. Additionally, RMSE and variance explained can be used to assess good choices of the number of factors.</p><p id="P40">Furthermore, guiding variables potentially driving variation in the data, need to be tested in multiple inference runs.</p></sec><sec id="S15"><title>Simulations</title><p id="P41">To verify that SOFA is able to both infer factors that approximate the multi-omic data and simultaneously guide a subset of the factor, we simulated data from the generative model, inferred a varying number of latent factors and computed the root mean square error between the reconstructed and the simulated data.</p><p id="P42"><xref ref-type="supplementary-material" rid="SD2">Fig. S1a</xref> shows the RMSE for the simulated multi-omic data for an unguided and a SOFA model where the first two factors were guided with simulated guide variables. The RMSE of the unguided model was slightly lower than that of the guided model. However, this was only the case for model fits with a lower number of factors than the simulated data. This indicates that if the number of latent factors is at least equal to the number of latent dimensions of the simulated data, SOFA is able to guide a subset of the factors without losing its ability to fit the multi-omic data. Furthermore, the simulated guide variables align with their respective guided factors (<xref ref-type="supplementary-material" rid="SD2">Fig. S1b,c</xref>).</p></sec><sec id="S16"><title>Comparison of SOFA and MOFA in the analysis of heart failure single-cell data</title><p id="P43">To investigate how guiding a subset of factors influences factorization, we applied SOFA for multicellular integration<sup><xref ref-type="bibr" rid="R21">21</xref></sup> to a collection of single-nucleus RNA-Seq data sets of acute and chronic human heart failure compiled in<sup><xref ref-type="bibr" rid="R22">22</xref></sup>. For each study, additionally, patient covariates such as age, sex and heart failure labels were available. Cell type annotations of each single-nucleus data were aligned to a unified ontology of seven cell-types: Cardiomyocytes, fibroblasts, pericytes, and endothelial, vascular smooth muscle, myeloid and lymphoid cells.</p><p id="P44">Pseudobulk expression profiles of each cell type per patient were used as input views for SOFA, as outlined in<sup><xref ref-type="bibr" rid="R21">21</xref></sup>. Briefly, pseudobulks for each cell type were included only if they contained at least 20 unique cells. Cell types present in fewer than 40% of the patients in a given data set were removed. At the gene level, genes expressed fewer than 20 times across 60% of the patients in a cell type were considered lowly expressed and filtered out. After this step, cell types with fewer than 50 expressed genes were discarded. Samples with less than 97% coverage of the filtered gene set were also excluded. Known background genes were removed, retaining only genes of interest for factor inference. Following these filtering steps, only cell types with at least 50 remaining genes were included in the final analysis.</p><p id="P45">We fit three models: a rank-10 MOFA model, a rank-10 SOFA model guided by age and sex, and a rank-10 SOFA model guided by age, sex, and heart failure. SOFA models were fitted with a total of 3500 steps and a learning rate of 0.01.</p><p id="P46">We identified factors associated with heart failure, sex, and age, and calculated the fraction of variance explained by these factors. This metric served as a proxy for the amount of variation in the omics data linked to heart failure, sex and age. Analysis of variance was used to associate factor scores with heart failure and sex, and Pearson correlation was used to test for association with age. When multiple factors associated with a covariate, we summed their fraction of variance explained.</p><p id="P47">To identify the most similar pair of heart failure-associated factors between the MOFA model and the SOFA model guided by age and sex in each study, we used absolute Spearman correlations of gene weights and factor scores, together with their fraction of explained variance. For each data set and model, we identified genes significantly associated with heart failure (adjusted p-value &lt;0.05), using the R package DESeq<sup><xref ref-type="bibr" rid="R79">79</xref></sup> with default parameters to filter out lowly expressed genes. We selected the number of significant genes among the highly ranked genes in the model by using their absolute factor loading as the basis for ranking. We then calculated recall, defined as the percentage of loadings that included these expected genes in the right regulatory direction.</p></sec></sec><sec id="S17"><title>Data processing</title><p id="P48">All data processing steps were performed using the <italic>muon</italic> (version 0.1.3)<sup><xref ref-type="bibr" rid="R80">80</xref></sup> and <italic>anndata</italic> (version 0.8.0)<sup><xref ref-type="bibr" rid="R81">81</xref></sup> Python packages.</p><sec id="S18"><title>TCGA pan-gynecologic atlas</title><p id="P49">All data modalities, survival data and metadata were downloaded using the R package <italic>curatedTCGAdata</italic> (version 1.26.0)<sup><xref ref-type="bibr" rid="R17">17</xref>,<xref ref-type="bibr" rid="R82">82</xref></sup>. All data modalities except the protein array data were log-transformed. All data was centered and scaled to unit variance. Before the analysis, we selected the top 2000 highly variable features of the RNA-seq and methylation data sets.</p></sec><sec id="S19"><title>Pan-cancer DepMap</title><p id="P50">We analyzed a multi-omic cancer cell line data set with proteomic data from Gonçalves et al.<sup><xref ref-type="bibr" rid="R18">18</xref></sup> combined with multi-omic and CRISPR essentiality data<sup><xref ref-type="bibr" rid="R19">19</xref>,<xref ref-type="bibr" rid="R48">48</xref></sup> of the same cell lines. Processed and transcript per million (TPM) normalized RNA-seq data<sup><xref ref-type="bibr" rid="R49">49</xref></sup>, mutation data<sup><xref ref-type="bibr" rid="R50">50</xref></sup> and integrated CRISPR essentiality scores were obtained from <ext-link ext-link-type="uri" xlink:href="https://cellmodelpassports.sanger.ac.uk/">https://cellmodelpassports.sanger.ac.uk/</ext-link><sup><xref ref-type="bibr" rid="R83">83</xref></sup>. Processed methylation beta values<sup><xref ref-type="bibr" rid="R50">50</xref></sup> were obtained from <ext-link ext-link-type="uri" xlink:href="https://www.cancerrxgene.org">https://www.cancerrxgene.org</ext-link>. Processed and normalized proteomics abundances and drug response lnIC50 data<sup><xref ref-type="bibr" rid="R50">50</xref></sup> was obtained via figshare from Gonçalves et al.<sup><xref ref-type="bibr" rid="R18">18</xref></sup>. We log-transformed, centered and scaled the RNA-seq TPM data and the pre-processed methylation beta values and selected the top 2000 highly variable genes prior to the analysis. The proteomics data was imputed with zero, and the top 2000 highly variable proteins were selected. Additionally, we regressed out the sample mean as suggested in Gonçalves et al.<sup><xref ref-type="bibr" rid="R18">18</xref></sup>. The drug response lnIC50 values were centered and scaled.</p></sec><sec id="S20"><title>Single-cell multi-omics of the human cerebral cortex</title><p id="P51">The single-cell RNA-seq and ATAC-seq data was obtained from Zhu et al.<sup><xref ref-type="bibr" rid="R20">20</xref></sup> and downloaded in the h5ad format from <ext-link ext-link-type="uri" xlink:href="https://cellxgene.cziscience.com/">https://cellxgene.cziscience.com/</ext-link>. RNA-seq data was normalized to library size and log-transformed. We selected the top 2000 highly variable genes in both modalities. Both data sets were centered and scaled before analysis. Cell type labels were obtained from the h5ad objects.</p></sec></sec><sec id="S21"><title>Downstream analysis</title><sec id="S22"><title>Association testing</title><p id="P52">Associations between factors and mutations were tested using two sample t-tests.</p><p id="P53">To test for associations between the guided SOFA factors and essentiality scores, we used factor values as predictors in a linear regression model to explain essentiality scores, and then evaluated the significance of the fitted regression coefficient. Briefly, Genes with highly negative CRISPR-Cas9 essentiality scores are deemed essential, as their loss significantly impairs cell viability. Scores near zero indicate nonessential genes with minimal impact on viability, while positive scores suggest that gene loss may confer a survival advantage. Therefore, negative coefficients (effect sizes) indicate that higher factor values correspond to lower essentiality scores, implying a decrease in cell viability. All p-values were adjusted for multiple testing using the Benjamini-Hochberg procedure<sup><xref ref-type="bibr" rid="R84">84</xref></sup>.</p></sec><sec id="S23"><title>Survival analysis</title><p id="P54">The survival analysis was performed using the <italic>lifelines</italic> package (version 0.27.7)<sup><xref ref-type="bibr" rid="R85">85</xref></sup>. Assessment of whether a factor was predictive of overall survival was done by per factor univariate Cox’s proportional hazard models. Resulting p-values were adjusted for multiple testing using the Benjamini-Hochberg procedure <sup><xref ref-type="bibr" rid="R84">84</xref></sup>.</p></sec><sec id="S24"><title>Gene set overrepresentation analysis (ORA)</title><p id="P55">To annotate the factors with biological processes we used the enrichr API<sup><xref ref-type="bibr" rid="R86">86</xref></sup> provided in the <italic>gseapy</italic> Python package (version 1.0.4) <sup><xref ref-type="bibr" rid="R87">87</xref></sup>. We used the top 100 features with highest or lowest loadings of a given factor and performed gene set overrepresentation analysis using all genes in the data set as background.</p></sec><sec id="S25"><title>Fraction of explained variance</title><p id="P56">Assuming the X data is centered, the fraction of variance that is explained by factor <italic>k</italic> of modality <italic>m</italic> was calculated as follows: <disp-formula id="FD3"><mml:math id="M13"><mml:mrow><mml:msup><mml:mi>R</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mstyle displaystyle="true"><mml:mo>Σ</mml:mo></mml:mstyle><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:msubsup><mml:msubsup><mml:mstyle displaystyle="true"><mml:mo>Σ</mml:mo></mml:mstyle><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msup><mml:mi>D</mml:mi><mml:mi>m</mml:mi></mml:msup></mml:mrow></mml:msubsup><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msubsup><mml:mi>w</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mrow><mml:msubsup><mml:mstyle displaystyle="true"><mml:mo>Σ</mml:mo></mml:mstyle><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:msubsup><mml:msubsup><mml:mstyle displaystyle="true"><mml:mo>Σ</mml:mo></mml:mstyle><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msup><mml:mi>D</mml:mi><mml:mi>m</mml:mi></mml:msup></mml:mrow></mml:msubsup><mml:msubsup><mml:mi>x</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula>
</p><p id="P57">Where the denominator corresponds to the total sum of squares of the centered data <bold>X</bold> and the nominator to the residual sum of squares. The fraction can be understood as the variability a given factor <italic>k</italic> accounts for.</p></sec><sec id="S26"><title>Two dimensional visualizations of the latent space</title><p id="P58">The t-distributed Stochastic Neighbor Embeddings (tSNE) for 2D visualizations of the latent space were calculated using the <italic>scikit-learn</italic> Python package (version 1.2.1)<sup><xref ref-type="bibr" rid="R88">88</xref></sup>. Uniform Manifold Approximation and Projection (UMAP)<sup><xref ref-type="bibr" rid="R89">89</xref></sup> embeddings were computed using the implementation provided in the <italic>scanpy</italic> Python package (version 1.9.3) <sup><xref ref-type="bibr" rid="R90">90</xref></sup>.</p></sec><sec id="S27"><title>Root mean square error for model selection</title><p id="P59">To assess the quality of the individual model fits we calculated the root mean square error as follows: <disp-formula id="FD4"><mml:math id="M14"><mml:mrow><mml:mtext>RMSE</mml:mtext><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msqrt><mml:mrow><mml:msubsup><mml:mstyle displaystyle="true"><mml:mo>Σ</mml:mo></mml:mstyle><mml:mrow><mml:mi>m</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>M</mml:mi></mml:msubsup><mml:msubsup><mml:mstyle displaystyle="true"><mml:mo>Σ</mml:mo></mml:mstyle><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>j</mml:mi></mml:msubsup><mml:msubsup><mml:mstyle displaystyle="true"><mml:mo>Σ</mml:mo></mml:mstyle><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mi>m</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msubsup><mml:mi>x</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msubsup><mml:mo>−</mml:mo><mml:msubsup><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:msqrt></mml:mrow><mml:mrow><mml:msubsup><mml:mstyle displaystyle="true"><mml:mo>Σ</mml:mo></mml:mstyle><mml:mrow><mml:mi>m</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>M</mml:mi></mml:msubsup><mml:mi>N</mml:mi><mml:mo>×</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mi>m</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p></sec><sec id="S28"><title>Adjusted Rand Index</title><p id="P60">To verify that the unguided factors did not capture variance associated with categorical guiding variables, such as cancer type labels, we compared the Adjusted Rand Index (ARI)<sup><xref ref-type="bibr" rid="R91">91</xref></sup> for clusterings on the latent factors of a guided vs unguided model. To this end, we used the <italic>scib</italic> package<sup><xref ref-type="bibr" rid="R92">92</xref></sup> to perform clustering on the latent factors and calculate the ARI between the cluster labels and categorical guiding variables for 10 independent initializations. The ARI measures how well the clusterings align with the guiding variables; a higher ARI corresponds to greater overlap, thus indicating that the latent factors captured variance associated with the guiding variables.</p></sec></sec><sec id="S29"><title>Software availability</title><p id="P61">SOFA is implemented in the Python package <italic>biosofa</italic> and is available on github (<ext-link ext-link-type="uri" xlink:href="https://github.com/tcapraz/SOFA">https://github.com/tcapraz/SOFA</ext-link>) and PyPI (<ext-link ext-link-type="uri" xlink:href="https://pypi.org/project/biosofa/">https://pypi.org/project/biosofa/</ext-link>), along with documentation and example analysis notebooks. Code and processed data to reproduce the analysis and figures are available on Zenodo <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.14761127">https://doi.org/10.5281/zenodo.14761127</ext-link>.</p></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Methods</label><media xlink:href="EMS199439-supplement-Supplementary_Methods.pdf" mimetype="application" mime-subtype="pdf" id="d41aAcHbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Supplementary Figures</label><media xlink:href="EMS199439-supplement-Supplementary_Figures.pdf" mimetype="application" mime-subtype="pdf" id="d41aAcHcB" position="anchor"/></supplementary-material></sec></body><back><ack id="S30"><title>Acknowledgements</title><p>We would like to thank Stefan Peidli and Martin Rohbeck for valuable feedback and discussions. We thank EMBL IT services and HPC resources for providing infrastructure to perform computations needed for this work. The results shown here are in part based upon data generated by the TCGA Research Network: <ext-link ext-link-type="uri" xlink:href="https://www.cancer.gov/tcga">https://www.cancer.gov/tcga</ext-link>.</p><sec id="S31"><title>Funding</title><p>This work was funded by the European Research Council (Synergy Grant DECODE under grant agreement no. 810296).</p></sec></ack><fn-group><fn fn-type="conflict" id="FN1"><p id="P62">Competing interests</p><p id="P63">Julio Saez-Rodriguez reports funding from GSK, Pfizer, AstraZeneca and Sanofi and fees/honoraria from Travere Therapeutics, Stadapharm, Astex, Pfizer, Grunenthal, Tempus, Moderna and Owkin.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>scNMT-seq enables joint profiling of chromatin accessibility DNA methylation and transcription in single cells</article-title><source>Nat Commun</source><year>2018</year><volume>9</volume><fpage>781</fpage><pub-id pub-id-type="pmcid">PMC5823944</pub-id><pub-id pub-id-type="pmid">29472610</pub-id><pub-id pub-id-type="doi">10.1038/s41467-018-03149-4</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoeckius</surname><given-names>M</given-names></name><etal/></person-group><article-title>Simultaneous epitope and transcriptome measurement in single cells</article-title><source>Nat Methods</source><year>2017</year><volume>14</volume><fpage>865</fpage><lpage>868</lpage><pub-id pub-id-type="pmcid">PMC5669064</pub-id><pub-id pub-id-type="pmid">28759029</pub-id><pub-id pub-id-type="doi">10.1038/nmeth.4380</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swanson</surname><given-names>E</given-names></name><etal/></person-group><article-title>Simultaneous trimodal single-cell measurement of transcripts, epitopes, and chromatin accessibility using TEA-seq</article-title><source>Elife</source><year>2021</year><volume>10</volume><pub-id pub-id-type="pmcid">PMC8034981</pub-id><pub-id pub-id-type="pmid">33835024</pub-id><pub-id pub-id-type="doi">10.7554/eLife.63632</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>S</given-names></name><etal/></person-group><article-title>Chromatin Potential Identified by Shared Single-Cell Profiling of RNA and Chromatin</article-title><source>Cell</source><year>2020</year><volume>183</volume><fpage>1103</fpage><lpage>1116</lpage><elocation-id>e20</elocation-id><pub-id pub-id-type="pmcid">PMC7669735</pub-id><pub-id pub-id-type="pmid">33098772</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.09.056</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotelling</surname><given-names>H</given-names></name></person-group><article-title>Relations Between Two Sets Of Variates</article-title><source>Biometrika</source><year>1936</year><volume>28</volume><fpage>321</fpage><lpage>377</lpage></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klami</surname><given-names>A</given-names></name><name><surname>Virtanen</surname><given-names>S</given-names></name><name><surname>Leppäaho</surname><given-names>E</given-names></name><name><surname>Kaski</surname><given-names>S</given-names></name></person-group><article-title>Group factor analysis</article-title><source>IEEE Trans Neural Netw Learn Syst</source><year>2015</year><volume>26</volume><fpage>2136</fpage><lpage>2147</lpage><pub-id pub-id-type="pmid">25532193</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Argelaguet</surname><given-names>R</given-names></name><etal/></person-group><article-title>Multi-Omics Factor Analysis-a framework for unsupervised integration of multi-omics data sets</article-title><source>Mol Syst Biol</source><year>2018</year><volume>14</volume><elocation-id>e8124</elocation-id><pub-id pub-id-type="pmcid">PMC6010767</pub-id><pub-id pub-id-type="pmid">29925568</pub-id><pub-id pub-id-type="doi">10.15252/msb.20178124</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>R</given-names></name><name><surname>Olshen</surname><given-names>AB</given-names></name><name><surname>Ladanyi</surname><given-names>M</given-names></name></person-group><article-title>Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis</article-title><source>Bioinformatics</source><year>2009</year><volume>25</volume><fpage>2906</fpage><lpage>2912</lpage><pub-id pub-id-type="pmcid">PMC2800366</pub-id><pub-id pub-id-type="pmid">19759197</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btp543</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Qoku</surname><given-names>A</given-names></name><name><surname>Buettner</surname><given-names>F</given-names></name></person-group><source>Encoding Domain Knowledge in Multi-view Latent Variable Models: A Bayesian Approach with Structured Sparsity</source><person-group person-group-type="editor"><name><surname>Ruiz</surname><given-names>F</given-names></name><name><surname>Dy</surname><given-names>J</given-names></name><name><surname>van de Meent</surname><given-names>J-W</given-names></name></person-group><conf-name>Proceedings of The 26th International Conference on Artificial Intelligence and Statistics</conf-name><conf-sponsor>PMLR</conf-sponsor><year>2023</year><month>Apr</month><day>25--27</day><volume>206</volume><fpage>11545</fpage><lpage>11562</lpage></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leek</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Tackling the widespread and critical impact of batch effects in high-throughput data</article-title><source>Nat Rev Genet</source><year>2010</year><volume>11</volume><fpage>733</fpage><lpage>739</lpage><pub-id pub-id-type="pmcid">PMC3880143</pub-id><pub-id pub-id-type="pmid">20838408</pub-id><pub-id pub-id-type="doi">10.1038/nrg2825</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia</article-title><source>Nat Cancer</source><year>2021</year><volume>2</volume><fpage>853</fpage><lpage>864</lpage><pub-id pub-id-type="pmcid">PMC7611543</pub-id><pub-id pub-id-type="pmid">34423310</pub-id><pub-id pub-id-type="doi">10.1038/s43018-021-00216-6</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jolliffe</surname><given-names>IT</given-names></name></person-group><article-title>A Note on the Use of Principal Components in Regression</article-title><source>J R Stat Soc Ser C Appl Stat</source><year>1982</year><volume>31</volume><fpage>300</fpage><lpage>303</lpage></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="other"><person-group person-group-type="author"><name><surname>Abdi</surname><given-names>H</given-names></name></person-group><source>Partial Least Squares (PLS) Regression</source><year>2003</year></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdi</surname><given-names>H</given-names></name></person-group><article-title>Partial least squares regression and projection on latent structure regression (PLS Regression</article-title><source>Wiley Interdiscip Rev Comput Stat</source><year>2010</year><volume>2</volume><fpage>97</fpage><lpage>106</lpage></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gygi</surname><given-names>JP</given-names></name><etal/></person-group><article-title>A supervised Bayesian factor model for the identification of multi-omics signatures</article-title><source>Bioinformatics</source><year>2024</year><volume>40</volume><pub-id pub-id-type="pmcid">PMC11078774</pub-id><pub-id pub-id-type="pmid">38603606</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btae202</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>A</given-names></name><etal/></person-group><article-title>DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays</article-title><source>Bioinformatics</source><year>2019</year><volume>35</volume><fpage>3055</fpage><lpage>3062</lpage><pub-id pub-id-type="pmcid">PMC6735831</pub-id><pub-id pub-id-type="pmid">30657866</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/bty1054</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Cancer Genome Atlas Research Network</collab><etal/></person-group><article-title>The Cancer Genome Atlas Pan-Cancer analysis project</article-title><source>Nat Genet</source><year>2013</year><volume>45</volume><fpage>1113</fpage><lpage>1120</lpage><pub-id pub-id-type="pmcid">PMC3919969</pub-id><pub-id pub-id-type="pmid">24071849</pub-id><pub-id pub-id-type="doi">10.1038/ng.2764</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonçalves</surname><given-names>E</given-names></name><etal/></person-group><article-title>Pan-cancer proteomic map of 949 human cell lines</article-title><source>Cancer Cell</source><year>2022</year><volume>40</volume><fpage>835</fpage><lpage>849</lpage><elocation-id>e8</elocation-id><pub-id pub-id-type="pmcid">PMC9387775</pub-id><pub-id pub-id-type="pmid">35839778</pub-id><pub-id pub-id-type="doi">10.1016/j.ccell.2022.06.010</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boehm</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Cancer research needs a better map</article-title><source>Nature</source><year>2021</year><volume>589</volume><fpage>514</fpage><lpage>516</lpage><pub-id pub-id-type="pmid">33500573</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>K</given-names></name><etal/></person-group><article-title>Multi-omic profiling of the developing human cerebral cortex at the single-cell level</article-title><source>Sci Adv</source><year>2023</year><volume>9</volume><elocation-id>eadg3754</elocation-id><pub-id pub-id-type="pmcid">PMC10569714</pub-id><pub-id pub-id-type="pmid">37824614</pub-id><pub-id pub-id-type="doi">10.1126/sciadv.adg3754</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez Flores</surname><given-names>RO</given-names></name><name><surname>Lanzer</surname><given-names>JD</given-names></name><name><surname>Dimitrov</surname><given-names>D</given-names></name><name><surname>Velten</surname><given-names>B</given-names></name><name><surname>Saez-Rodriguez</surname><given-names>J</given-names></name></person-group><article-title>Multicellular factor analysis of single-cell data for a tissue-centric understanding of disease</article-title><source>Elife</source><year>2023</year><volume>12</volume><pub-id pub-id-type="pmcid">PMC10718529</pub-id><pub-id pub-id-type="pmid">37991480</pub-id><pub-id pub-id-type="doi">10.7554/eLife.93161</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanzer</surname><given-names>JD</given-names></name><name><surname>Ramirez Flores</surname><given-names>RO</given-names></name><name><surname>Liñares Blanco</surname><given-names>J</given-names></name><name><surname>Saez-Rodriguez</surname><given-names>J</given-names></name></person-group><article-title>A cross-study transcriptional patient map of heart failure defines conserved multicellular coordination in cardiac remodeling</article-title><source>bioRxiv</source><year>2024</year><pub-id pub-id-type="doi">10.1101/2024.11.04.621815</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaffin</surname><given-names>M</given-names></name><etal/></person-group><article-title>Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy</article-title><source>Nature</source><year>2022</year><volume>608</volume><fpage>174</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">35732739</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koenig</surname><given-names>AL</given-names></name><etal/></person-group><article-title>Single-cell transcriptomics reveals cell-type-specific diversification in human heart failure</article-title><source>Nat Cardiovasc Res</source><year>2022</year><volume>1</volume><fpage>263</fpage><lpage>280</lpage><pub-id pub-id-type="pmcid">PMC9364913</pub-id><pub-id pub-id-type="pmid">35959412</pub-id><pub-id pub-id-type="doi">10.1038/s44161-022-00028-6</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reichart</surname><given-names>D</given-names></name><etal/></person-group><article-title>Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies</article-title><source>Science</source><year>2022</year><volume>377</volume><elocation-id>eabo1984</elocation-id><pub-id pub-id-type="pmcid">PMC9528698</pub-id><pub-id pub-id-type="pmid">35926050</pub-id><pub-id pub-id-type="doi">10.1126/science.abo1984</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simonson</surname><given-names>B</given-names></name><etal/></person-group><article-title>Single-nucleus RNA sequencing in ischemic cardiomyopathy reveals common transcriptional profile underlying end-stage heart failure</article-title><source>Cell Rep</source><year>2023</year><volume>42</volume><elocation-id>112086</elocation-id><pub-id pub-id-type="pmcid">PMC10423750</pub-id><pub-id pub-id-type="pmid">36790929</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2023.112086</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>CM</given-names></name><name><surname>Polson</surname><given-names>NG</given-names></name><name><surname>Scott</surname><given-names>JG</given-names></name></person-group><source>Handling Sparsity via the Horseshoe</source><person-group person-group-type="editor"><name><surname>van Dyk</surname><given-names>D</given-names></name><name><surname>Welling</surname><given-names>M</given-names></name></person-group><conf-name>Proceedings of the Twelth International Conference on Artificial Intelligence and Statistics</conf-name><conf-sponsor>PMLR, Hilton Clearwater Beach Resort</conf-sponsor><conf-loc>Clearwater Beach, Florida USA</conf-loc><year>2009</year><month>Apr</month><day>16--18</day><volume>5</volume><fpage>73</fpage><lpage>80</lpage></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><collab>The Cancer Genome Atlas Research Network</collab><article-title>Integrated genomic and molecular characterization of cervical cancer</article-title><source>Nature</source><year>2017</year><volume>543</volume><fpage>378</fpage><lpage>384</lpage><pub-id pub-id-type="pmcid">PMC5354998</pub-id><pub-id pub-id-type="pmid">28112728</pub-id><pub-id pub-id-type="doi">10.1038/nature21386</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><collab>Cancer Genome Atlas Network</collab><article-title>Comprehensive molecular portraits of human breast tumours</article-title><source>Nature</source><year>2012</year><volume>490</volume><fpage>61</fpage><lpage>70</lpage><pub-id pub-id-type="pmcid">PMC3465532</pub-id><pub-id pub-id-type="pmid">23000897</pub-id><pub-id pub-id-type="doi">10.1038/nature11412</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherniack</surname><given-names>AD</given-names></name><etal/></person-group><article-title>Integrated molecular characterization of uterine carcinosarcoma</article-title><source>Cancer Cell</source><year>2017</year><volume>31</volume><fpage>411</fpage><lpage>423</lpage><pub-id pub-id-type="pmcid">PMC5599133</pub-id><pub-id pub-id-type="pmid">28292439</pub-id><pub-id pub-id-type="doi">10.1016/j.ccell.2017.02.010</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Cancer Genome Atlas Research Network</collab><etal/></person-group><article-title>Integrated genomic characterization of endometrial carcinoma</article-title><source>Nature</source><year>2013</year><volume>497</volume><fpage>67</fpage><lpage>73</lpage><pub-id pub-id-type="pmcid">PMC3704730</pub-id><pub-id pub-id-type="pmid">23636398</pub-id><pub-id pub-id-type="doi">10.1038/nature12113</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iorio</surname><given-names>MV</given-names></name><etal/></person-group><article-title>MicroRNA signatures in human ovarian cancer</article-title><source>Cancer Res</source><year>2007</year><volume>67</volume><fpage>8699</fpage><lpage>8707</lpage><pub-id pub-id-type="pmid">17875710</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name></person-group><article-title>The role of miRNA in ovarian cancer: An overview</article-title><source>Reprod Sci</source><year>2022</year><volume>29</volume><fpage>2760</fpage><lpage>2767</lpage><pub-id pub-id-type="pmcid">PMC9537199</pub-id><pub-id pub-id-type="pmid">34973152</pub-id><pub-id pub-id-type="doi">10.1007/s43032-021-00717-w</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>LC</given-names></name><etal/></person-group><article-title>Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses’ Health Study</article-title><source>Mod Pathol</source><year>2011</year><volume>24</volume><fpage>924</fpage><lpage>931</lpage><pub-id pub-id-type="pmcid">PMC3128675</pub-id><pub-id pub-id-type="pmid">21552212</pub-id><pub-id pub-id-type="doi">10.1038/modpathol.2011.54</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pichon</surname><given-names>MF</given-names></name><name><surname>Pallud</surname><given-names>C</given-names></name><name><surname>Brunet</surname><given-names>M</given-names></name><name><surname>Milgrom</surname><given-names>E</given-names></name></person-group><article-title>Relationship of presence of progesterone receptors to prognosis in early breast cancer</article-title><source>Cancer Res</source><year>1980</year><volume>40</volume><fpage>3357</fpage><lpage>3360</lpage><pub-id pub-id-type="pmid">7427948</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perou</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Molecular portraits of human breast tumours</article-title><source>Nature</source><year>2000</year><volume>406</volume><fpage>747</fpage><lpage>752</lpage><pub-id pub-id-type="pmid">10963602</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sivakumar</surname><given-names>S</given-names></name><etal/></person-group><article-title>Basal cell adhesion molecule promotes metastasis-associated processes in ovarian cancer</article-title><source>Clin Transl Med</source><year>2023</year><volume>13</volume><elocation-id>e1176</elocation-id><pub-id pub-id-type="pmcid">PMC9842900</pub-id><pub-id pub-id-type="pmid">36647260</pub-id><pub-id pub-id-type="doi">10.1002/ctm2.1176</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>MA</given-names></name><name><surname>Babbs</surname><given-names>B</given-names></name><name><surname>Cochrane</surname><given-names>DR</given-names></name><name><surname>Bitler</surname><given-names>BG</given-names></name><name><surname>Richer</surname><given-names>JK</given-names></name></person-group><article-title>The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing</article-title><source>Mol Carcinog</source><year>2019</year><volume>58</volume><fpage>196</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">30294913</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netinatsunthorn</surname><given-names>W</given-names></name><name><surname>Hanprasertpong</surname><given-names>J</given-names></name><name><surname>Dechsukhum</surname><given-names>C</given-names></name><name><surname>Leetanaporn</surname><given-names>R</given-names></name><name><surname>Geater</surname><given-names>A</given-names></name></person-group><article-title>WT1 gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study</article-title><source>BMC Cancer</source><year>2006</year><volume>6</volume><fpage>90</fpage><pub-id pub-id-type="pmcid">PMC1479357</pub-id><pub-id pub-id-type="pmid">16606472</pub-id><pub-id pub-id-type="doi">10.1186/1471-2407-6-90</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name></person-group><article-title>Role of programmed cell death 4 in diseases: a double-edged sword</article-title><source>Cell Mol Immunol</source><year>2017</year><volume>14</volume><fpage>884</fpage><lpage>886</lpage><pub-id pub-id-type="pmcid">PMC5675960</pub-id><pub-id pub-id-type="pmid">28920585</pub-id><pub-id pub-id-type="doi">10.1038/cmi.2017.84</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>L</given-names></name><etal/></person-group><article-title>NTN4 as a prognostic marker and a hallmark for immune infiltration in breast cancer</article-title><source>Sci Rep</source><year>2022</year><volume>12</volume><elocation-id>10567</elocation-id><pub-id pub-id-type="pmcid">PMC9217917</pub-id><pub-id pub-id-type="pmid">35732855</pub-id><pub-id pub-id-type="doi">10.1038/s41598-022-14575-2</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarmoko</surname></name><name><surname>Ramadhanti</surname><given-names>M</given-names></name><name><surname>Zulkepli</surname><given-names>NA</given-names></name></person-group><article-title>CD59: Biological function and its potential for drug target action</article-title><source>Gene Reports</source><year>2023</year><volume>31</volume><elocation-id>101772</elocation-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title>The prognostic value of plasma complement factor B (CFB) in thyroid carcinoma</article-title><source>Bioengineered</source><year>2021</year><volume>12</volume><fpage>12854</fpage><lpage>12866</lpage><pub-id pub-id-type="pmcid">PMC8810132</pub-id><pub-id pub-id-type="pmid">34898340</pub-id><pub-id pub-id-type="doi">10.1080/21655979.2021.2005745</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Earnshaw</surname><given-names>WC</given-names></name><name><surname>Halligan</surname><given-names>B</given-names></name><name><surname>Cooke</surname><given-names>CA</given-names></name><name><surname>Heck</surname><given-names>MM</given-names></name><name><surname>Liu</surname><given-names>LF</given-names></name></person-group><article-title>Topoisomerase II is a structural component of mitotic chromosome scaffolds</article-title><source>J Cell Biol</source><year>1985</year><volume>100</volume><fpage>1706</fpage><lpage>1715</lpage><pub-id pub-id-type="pmcid">PMC2113886</pub-id><pub-id pub-id-type="pmid">2985625</pub-id><pub-id pub-id-type="doi">10.1083/jcb.100.5.1706</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wittmann</surname><given-names>T</given-names></name><name><surname>Boleti</surname><given-names>H</given-names></name><name><surname>Antony</surname><given-names>C</given-names></name><name><surname>Karsenti</surname><given-names>E</given-names></name><name><surname>Vernos</surname><given-names>I</given-names></name></person-group><article-title>Localization of the kinesin-like protein Xklp2 to spindle poles requires a leucine zipper, a microtubule-associated protein, and dynein</article-title><source>J Cell Biol</source><year>1998</year><volume>143</volume><fpage>673</fpage><lpage>685</lpage><pub-id pub-id-type="pmcid">PMC2148133</pub-id><pub-id pub-id-type="pmid">9813089</pub-id><pub-id pub-id-type="doi">10.1083/jcb.143.3.673</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>J</given-names></name><etal/></person-group><article-title>Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells</article-title><source>Oncogene</source><year>2004</year><volume>23</volume><fpage>5843</fpage><lpage>5852</lpage><pub-id pub-id-type="pmid">15208674</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>M</given-names></name><name><surname>Müller</surname><given-names>GA</given-names></name></person-group><article-title>Cell cycle transcription control: DREAM/MuvB and RB-E2F complexes</article-title><source>Crit Rev Biochem Mol Biol</source><year>2017</year><volume>52</volume><fpage>638</fpage><lpage>662</lpage><pub-id pub-id-type="pmid">28799433</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacini</surname><given-names>C</given-names></name><etal/></person-group><article-title>Integrated cross-study datasets of genetic dependencies in cancer</article-title><source>Nat Commun</source><year>2021</year><volume>12</volume><elocation-id>1661</elocation-id><pub-id pub-id-type="pmcid">PMC7955067</pub-id><pub-id pub-id-type="pmid">33712601</pub-id><pub-id pub-id-type="doi">10.1038/s41467-021-21898-7</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Alonso</surname><given-names>L</given-names></name><etal/></person-group><article-title>Transcription factor activities enhance markers of drug sensitivity in cancer</article-title><source>Cancer Res</source><year>2018</year><volume>78</volume><fpage>769</fpage><lpage>780</lpage><pub-id pub-id-type="pmcid">PMC6522379</pub-id><pub-id pub-id-type="pmid">29229604</pub-id><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-17-1679</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iorio</surname><given-names>F</given-names></name><etal/></person-group><article-title>A landscape of pharmacogenomic interactions in cancer</article-title><source>Cell</source><year>2016</year><volume>166</volume><fpage>740</fpage><lpage>754</lpage><pub-id pub-id-type="pmcid">PMC4967469</pub-id><pub-id pub-id-type="pmid">27397505</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2016.06.017</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maldonado</surname><given-names>JL</given-names></name><name><surname>Fridlyand</surname><given-names>J</given-names></name><name><surname>Bastian</surname><given-names>BC</given-names></name></person-group><article-title>RESPONSE: Re: Determinants of BRAF mutations in primary melanomas</article-title><source>J Natl Cancer Inst</source><year>2005</year><volume>97</volume><fpage>402</fpage><pub-id pub-id-type="pmid">15741578</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yammine</surname><given-names>L</given-names></name><name><surname>Zablocki</surname><given-names>A</given-names></name><name><surname>Baron</surname><given-names>W</given-names></name><name><surname>Terzi</surname><given-names>F</given-names></name><name><surname>Gallazzini</surname><given-names>M</given-names></name></person-group><article-title>Lipocalin-2 Regulates Epidermal Growth Factor Receptor Intracellular Trafficking</article-title><source>Cell Rep</source><year>2019</year><volume>29</volume><fpage>2067</fpage><lpage>2077</lpage><elocation-id>e6</elocation-id><pub-id pub-id-type="pmid">31722218</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoll</surname><given-names>SW</given-names></name><etal/></person-group><article-title>The EGF receptor ligand amphiregulin controls cell division via FoxM1</article-title><source>Oncogene</source><year>2016</year><volume>35</volume><fpage>2075</fpage><lpage>2086</lpage><pub-id pub-id-type="pmcid">PMC4788585</pub-id><pub-id pub-id-type="pmid">26234682</pub-id><pub-id pub-id-type="doi">10.1038/onc.2015.269</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>D</given-names></name><etal/></person-group><article-title>LAMC2 promotes EGFR cell membrane localization and acts as a novel biomarker for tyrosine kinase inhibitors (TKIs) sensitivity in lung cancer</article-title><source>Cancer Gene Ther</source><year>2023</year><volume>30</volume><fpage>1498</fpage><lpage>1512</lpage><pub-id pub-id-type="pmcid">PMC10645587</pub-id><pub-id pub-id-type="pmid">37542131</pub-id><pub-id pub-id-type="doi">10.1038/s41417-023-00654-7</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Z-Z</given-names></name><etal/></person-group><article-title>The miR-1224-5p/TNS4/EGFR axis inhibits tumour progression in oesophageal squamous cell carcinoma</article-title><source>Cell Death Dis</source><year>2020</year><volume>11</volume><fpage>597</fpage><pub-id pub-id-type="pmcid">PMC7393493</pub-id><pub-id pub-id-type="pmid">32732965</pub-id><pub-id pub-id-type="doi">10.1038/s41419-020-02801-6</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coulombe</surname><given-names>PA</given-names></name><name><surname>Orosco</surname><given-names>A</given-names></name></person-group><article-title>Inhibiting EGFR Signaling Holds Promise for Treating Palmoplantar Keratodermas</article-title><source>J Invest Dermatol</source><year>2023</year><volume>143</volume><fpage>185</fpage><lpage>188</lpage><pub-id pub-id-type="pmcid">PMC10166065</pub-id><pub-id pub-id-type="pmid">36681421</pub-id><pub-id pub-id-type="doi">10.1016/j.jid.2022.09.653</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fearon</surname><given-names>ER</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name></person-group><article-title>A genetic model for colorectal tumorigenesis</article-title><source>Cell</source><year>1990</year><volume>61</volume><fpage>759</fpage><lpage>767</lpage><pub-id pub-id-type="pmid">2188735</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malki</surname><given-names>A</given-names></name><etal/></person-group><article-title>Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements</article-title><source>Int J Mol Sci</source><year>2020</year><volume>22</volume><pub-id pub-id-type="pmcid">PMC7794761</pub-id><pub-id pub-id-type="pmid">33374459</pub-id><pub-id pub-id-type="doi">10.3390/ijms22010130</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brescia</surname><given-names>P</given-names></name><etal/></person-group><article-title>MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis</article-title><source>Cancer Cell</source><year>2018</year><volume>34</volume><fpage>453</fpage><lpage>465</lpage><elocation-id>e9</elocation-id><pub-id pub-id-type="pmcid">PMC6223119</pub-id><pub-id pub-id-type="pmid">30205047</pub-id><pub-id pub-id-type="doi">10.1016/j.ccell.2018.08.006</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nutt</surname><given-names>SL</given-names></name><name><surname>Heavey</surname><given-names>B</given-names></name><name><surname>Rolink</surname><given-names>AG</given-names></name><name><surname>Busslinger</surname><given-names>M</given-names></name></person-group><article-title>Commitment to the B-lymphoid lineage depends on the transcription factor Pax5</article-title><source>Nature</source><year>1999</year><volume>401</volume><fpage>556</fpage><lpage>562</lpage></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>B</given-names></name><name><surname>Amanullah</surname><given-names>A</given-names></name><name><surname>Shafarenko</surname><given-names>M</given-names></name><name><surname>Liebermann</surname><given-names>DA</given-names></name></person-group><article-title>The proto-oncogene c-myc in hematopoietic development and leukemogenesis</article-title><source>Oncogene</source><year>2002</year><volume>21</volume><fpage>3414</fpage><lpage>3421</lpage><pub-id pub-id-type="pmid">12032779</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kundu</surname><given-names>M</given-names></name><etal/></person-group><article-title>Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11</article-title><source>Blood</source><year>2002</year><volume>100</volume><fpage>2449</fpage><lpage>2456</lpage><pub-id pub-id-type="pmid">12239155</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeSilva</surname><given-names>TM</given-names></name><name><surname>Borenstein</surname><given-names>NS</given-names></name><name><surname>Volpe</surname><given-names>JJ</given-names></name><name><surname>Kinney</surname><given-names>HC</given-names></name><name><surname>Rosenberg</surname><given-names>PA</given-names></name></person-group><article-title>Expression of EAAT2 in neurons and protoplasmic astrocytes during human cortical development</article-title><source>J Comp Neurol</source><year>2012</year><volume>520</volume><fpage>3912</fpage><lpage>3932</lpage><pub-id pub-id-type="pmcid">PMC3781602</pub-id><pub-id pub-id-type="pmid">22522966</pub-id><pub-id pub-id-type="doi">10.1002/cne.23130</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anlauf</surname><given-names>E</given-names></name><name><surname>Derouiche</surname><given-names>A</given-names></name></person-group><article-title>Glutamine synthetase as an astrocytic marker: its cell type and vesicle localization</article-title><source>Front Endocrinol</source><year>2013</year><volume>4</volume><fpage>144</fpage><pub-id pub-id-type="pmcid">PMC3797418</pub-id><pub-id pub-id-type="pmid">24137157</pub-id><pub-id pub-id-type="doi">10.3389/fendo.2013.00144</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagan</surname><given-names>N</given-names></name><etal/></person-group><article-title>CSF1R signaling is a regulator of pathogenesis in progressive MS</article-title><source>Cell Death Dis</source><year>2020</year><volume>11</volume><fpage>904</fpage><pub-id pub-id-type="pmcid">PMC7584629</pub-id><pub-id pub-id-type="pmid">33097690</pub-id><pub-id pub-id-type="doi">10.1038/s41419-020-03084-7</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><etal/></person-group><article-title>Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer’s disease</article-title><source>Cell</source><year>2013</year><volume>153</volume><fpage>707</fpage><lpage>720</lpage><pub-id pub-id-type="pmcid">PMC3677161</pub-id><pub-id pub-id-type="pmid">23622250</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2013.03.030</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>Y</given-names></name><name><surname>Yona</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>K-W</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name></person-group><article-title>Microglia, seen from the CX3CR1 angle</article-title><source>Front Cell Neurosci</source><year>2013</year><volume>7</volume><fpage>26</fpage><pub-id pub-id-type="pmcid">PMC3600435</pub-id><pub-id pub-id-type="pmid">23507975</pub-id><pub-id pub-id-type="doi">10.3389/fncel.2013.00026</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ainger</surname><given-names>K</given-names></name><etal/></person-group><article-title>Transport and localization of exogenous myelin basic protein mRNA microinjected into oligodendrocytes</article-title><source>J Cell Biol</source><year>1993</year><volume>123</volume><fpage>431</fpage><lpage>441</lpage><pub-id pub-id-type="pmcid">PMC2119827</pub-id><pub-id pub-id-type="pmid">7691830</pub-id><pub-id pub-id-type="doi">10.1083/jcb.123.2.431</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><article-title>Oligodendrocytic Basic Protein: Identification of an Encephalitogenic Epitope and Association with Multiple Sclerosis1</article-title><pub-id pub-id-type="pmid">10623862</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>An</surname><given-names>H</given-names></name><name><surname>Fan</surname><given-names>C</given-names></name><name><surname>Park</surname><given-names>Y</given-names></name></person-group><article-title>Identifying oligodendrocyte enhancers governing Plp1 expression</article-title><source>Hum Mol Genet</source><year>2021</year><volume>30</volume><fpage>2225</fpage><lpage>2239</lpage><pub-id pub-id-type="pmcid">PMC8600034</pub-id><pub-id pub-id-type="pmid">34230963</pub-id><pub-id pub-id-type="doi">10.1093/hmg/ddab184</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masuda</surname><given-names>T</given-names></name><name><surname>Sankowski</surname><given-names>R</given-names></name><name><surname>Staszewski</surname><given-names>O</given-names></name><name><surname>Prinz</surname><given-names>M</given-names></name></person-group><article-title>Microglia Heterogeneity in the Single-Cell Era</article-title><source>Cell Rep</source><year>2020</year><volume>30</volume><fpage>1271</fpage><lpage>1281</lpage><pub-id pub-id-type="pmid">32023447</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammond</surname><given-names>TR</given-names></name><etal/></person-group><article-title>Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes</article-title><source>Immunity</source><year>2019</year><volume>50</volume><fpage>253</fpage><lpage>271</lpage><elocation-id>e6</elocation-id><pub-id pub-id-type="pmcid">PMC6655561</pub-id><pub-id pub-id-type="pmid">30471926</pub-id><pub-id pub-id-type="doi">10.1016/j.immuni.2018.11.004</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thion</surname><given-names>MS</given-names></name><name><surname>Ginhoux</surname><given-names>F</given-names></name><name><surname>Garel</surname><given-names>S</given-names></name></person-group><article-title>Microglia and early brain development: An intimate journey</article-title><source>Science</source><year>2018</year><volume>362</volume><fpage>185</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">30309946</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schalbetter</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Adolescence is a sensitive period for prefrontal microglia to act on cognitive development</article-title><source>Sci Adv</source><year>2022</year><volume>8</volume><elocation-id>eabi6672</elocation-id><pub-id pub-id-type="pmcid">PMC8890703</pub-id><pub-id pub-id-type="pmid">35235358</pub-id><pub-id pub-id-type="doi">10.1126/sciadv.abi6672</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barkley</surname><given-names>D</given-names></name><etal/></person-group><article-title>Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment</article-title><source>Nat Genet</source><year>2022</year><volume>54</volume><fpage>1192</fpage><lpage>1201</lpage><pub-id pub-id-type="pmcid">PMC9886402</pub-id><pub-id pub-id-type="pmid">35931863</pub-id><pub-id pub-id-type="doi">10.1038/s41588-022-01141-9</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Bingham</surname><given-names>E</given-names></name><etal/></person-group><source>Pyro: Deep universal probabilistic programming</source><comment><ext-link ext-link-type="uri" xlink:href="https://www.jmlr.org/papers/volume20/18-403/18-403.pdf">https://www.jmlr.org/papers/volume20/18-403/18-403.pdf</ext-link></comment></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Ranganath</surname><given-names>R</given-names></name><name><surname>Gerrish</surname><given-names>S</given-names></name><name><surname>Blei</surname><given-names>D</given-names></name></person-group><source>Black Box Variational Inference</source><person-group person-group-type="editor"><name><surname>Kaski</surname><given-names>S</given-names></name><name><surname>Corander</surname><given-names>J</given-names></name></person-group><conf-name>Proceedings of the Seventeenth International Conference on Artificial Intelligence and Statistics</conf-name><conf-sponsor>PMLR</conf-sponsor><conf-loc>Reykjavik, Iceland</conf-loc><year>2014</year><month>Apr</month><day>22--25</day><volume>33</volume><fpage>814</fpage><lpage>822</lpage></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>M</given-names></name><name><surname>Blei</surname><given-names>DM</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Paisley</surname><given-names>J</given-names></name></person-group><article-title>Stochastic Variational Inference</article-title><source>arXiv [statML]</source><year>2012</year><fpage>1303</fpage><lpage>1347</lpage></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biol</source><year>2014</year><volume>15</volume><fpage>550</fpage><pub-id pub-id-type="pmcid">PMC4302049</pub-id><pub-id pub-id-type="pmid">25516281</pub-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bredikhin</surname><given-names>D</given-names></name><name><surname>Kats</surname><given-names>I</given-names></name><name><surname>Stegle</surname><given-names>O</given-names></name></person-group><article-title>MUON: multimodal omics analysis framework</article-title><source>Genome Biol</source><year>2022</year><volume>23</volume><fpage>42</fpage><pub-id pub-id-type="pmcid">PMC8805324</pub-id><pub-id pub-id-type="pmid">35105358</pub-id><pub-id pub-id-type="doi">10.1186/s13059-021-02577-8</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virshup</surname><given-names>I</given-names></name><name><surname>Rybakov</surname><given-names>S</given-names></name><name><surname>Theis</surname><given-names>FJ</given-names></name><name><surname>Angerer</surname><given-names>P</given-names></name><name><surname>Alexander Wolf</surname><given-names>F</given-names></name></person-group><article-title>anndata: Annotated data</article-title><source>bioRxiv</source><year>2021</year><elocation-id>2021.12.16.473007</elocation-id><pub-id pub-id-type="doi">10.1101/2021.12.16.473007</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos</surname><given-names>M</given-names></name><etal/></person-group><article-title>Multiomic Integration of Public Oncology Databases in Bioconductor</article-title><source>JCO Clin Cancer Inform</source><year>2020</year><volume>4</volume><fpage>958</fpage><lpage>971</lpage><pub-id pub-id-type="pmcid">PMC7608653</pub-id><pub-id pub-id-type="pmid">33119407</pub-id><pub-id pub-id-type="doi">10.1200/CCI.19.00119</pub-id></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Meer</surname><given-names>D</given-names></name><etal/></person-group><article-title>Cell Model Passports-a hub for clinical, genetic and functional datasets of preclinical cancer models</article-title><source>Nucleic Acids Res</source><year>2019</year><volume>47</volume><fpage>D923</fpage><lpage>D929</lpage><pub-id pub-id-type="pmcid">PMC6324059</pub-id><pub-id pub-id-type="pmid">30260411</pub-id><pub-id pub-id-type="doi">10.1093/nar/gky872</pub-id></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamini</surname><given-names>Y</given-names></name><name><surname>Hochberg</surname><given-names>Y</given-names></name></person-group><article-title>Controlling the false discovery rate: A practical and powerful approach to multiple testing</article-title><source>J R Stat Soc</source><year>1995</year><volume>57</volume><fpage>289</fpage><lpage>300</lpage></element-citation></ref><ref id="R85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson-Pilon</surname><given-names>C</given-names></name></person-group><article-title>lifelines: survival analysis in Python</article-title><source>J Open Source Softw</source><year>2019</year><volume>4</volume><elocation-id>1317</elocation-id></element-citation></ref><ref id="R86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>EY</given-names></name><etal/></person-group><article-title>Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool</article-title><source>BMC Bioinformatics</source><year>2013</year><volume>14</volume><fpage>128</fpage><pub-id pub-id-type="pmcid">PMC3637064</pub-id><pub-id pub-id-type="pmid">23586463</pub-id><pub-id pub-id-type="doi">10.1186/1471-2105-14-128</pub-id></element-citation></ref><ref id="R87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>GSEApy</surname><given-names>GP</given-names></name></person-group><article-title>A comprehensive package for performing gene set enrichment analysis in Python</article-title><year>2023</year><volume>39</volume><elocation-id>btac757</elocation-id><pub-id pub-id-type="pmcid">PMC9805564</pub-id><pub-id pub-id-type="pmid">36426870</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btac757</pub-id></element-citation></ref><ref id="R88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedregosa</surname><given-names>F</given-names></name><etal/></person-group><article-title>Scikit-learn: Machine Learning in Python</article-title><source>J Mach Learn Res</source><year>2011</year><elocation-id>abs/1201.0490</elocation-id></element-citation></ref><ref id="R89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McInnes</surname><given-names>L</given-names></name><name><surname>Healy</surname><given-names>J</given-names></name><name><surname>Melville</surname><given-names>J</given-names></name></person-group><article-title>UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction</article-title><source>arXiv [statML]</source><year>2018</year></element-citation></ref><ref id="R90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>FA</given-names></name><name><surname>Angerer</surname><given-names>P</given-names></name><name><surname>Theis</surname><given-names>FJ</given-names></name></person-group><article-title>SCANPY: large-scale single-cell gene expression data analysis</article-title><source>Genome Biol</source><year>2018</year><volume>19</volume><fpage>15</fpage><pub-id pub-id-type="pmcid">PMC5802054</pub-id><pub-id pub-id-type="pmid">29409532</pub-id><pub-id pub-id-type="doi">10.1186/s13059-017-1382-0</pub-id></element-citation></ref><ref id="R91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morey</surname><given-names>LC</given-names></name><name><surname>Agresti</surname><given-names>A</given-names></name></person-group><article-title>The measurement of classification agreement: An adjustment to the Rand statistic for chance agreement</article-title><source>Educ Psychol Meas</source><year>1984</year><volume>44</volume><fpage>33</fpage><lpage>37</lpage></element-citation></ref><ref id="R92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luecken</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Benchmarking atlas-level data integration in single-cell genomics</article-title><source>Nat Methods</source><year>2022</year><volume>19</volume><fpage>41</fpage><lpage>50</lpage><pub-id pub-id-type="pmcid">PMC8748196</pub-id><pub-id pub-id-type="pmid">34949812</pub-id><pub-id pub-id-type="doi">10.1038/s41592-021-01336-8</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>a</bold>: The SOFA model. Input data modalities X are decomposed into shared latent factors Z and modality specific feature loadings W. A hierarchical horseshoe prior shrinks the loading weights on the view, factor and feature level. This leads to factors shared between all views, factors active in one view and factors shared between subsets of views. <bold>b:</bold> Guided factors are linked to the guide variables. <bold>c:</bold> Factors not linked to a guide variable capture potentially novel sources of variation. Factors and loadings can be used for various sample- and feature-level downstream analyses.</p></caption><graphic xlink:href="EMS199439-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>a:</bold> Distributions of guided factors colored by their guiding variables (orange). <bold>b</bold>: Top: Hazard ratios from univariate Cox regression for each factor on overall survival. Hazard ratios &gt; 1 indicate that positive factor values are associated with higher risk. Hazard ratios are colored if adjusted p-values are lower than 0.01. P-values were adjusted for multiple testing using the Benjamini-Hochberg (BH) method. Bottom: Variance explained by each factor for each modality. <bold>c</bold>: Kaplan-Meier curves showing progression free survival (left) and overall survival (right) for samples with factor values &lt; 50th and &gt; 95th percentiles of Factor 10. <bold>d</bold>: Features with the highest absolute loading weights for factor 10 in transcriptomics (left) and proteomics loadings (right). <bold>e</bold>: Gene set overrepresentation analysis for the transcriptomics features with the highest absolute loadings of factor 10. The -log10 adjusted p-values are multiplied by the sign of the loadings to reflect the direction of the association with the factor. Cancer types shown: brca: breast invasive carcinoma; cesc: Cervical squamous cell carcinoma and endocervical adenocarcinoma; ov: Ovarian serous cystadenocarcinoma; ucec: Uterine Corpus Endometrial Carcinoma; ucs: Uterine Carcinosarcoma</p></caption><graphic xlink:href="EMS199439-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>a:</bold> tSNE of all SOFA factors, colored by cancer types. <bold>b</bold>: Variance explained by each factor for each modality. <bold>c</bold>: Distributions of guided factors colored by their guiding variables (orange). <bold>d</bold>: Distribution of Factor 10 cell lines from the respiratory system are colored (left). Distribution of Factor 10 for cell lines from non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) (right). <bold>e</bold>: Highest absolute transcriptomics (left) and drug response (right) loadings of Factor 10. <bold>f</bold>: Heatmap showing CRISPR essentiality scores (ES) of top 10 genes significantly associated with Factor 10, tested using a linear model. The cell lines are ordered based on their values of Factor 10. <bold>g</bold>: Distribution of Factor 12, cell lines from the circulatory system are colored (left). Distribution of Factor 12 for B-cell, T-cell and myeloid cell lines (right). <bold>h</bold>: Volcano plot of associations between Factor 10 and mutations, tested using a two sample t-test. BH-adjusted p-values &lt; 0.05 are highlighted in color. Genes colored in blue are significantly associated with higher and genes colored in red with lower factor values. <bold>i</bold>: Heatmap showing CRISPR essentiality scores (ES) of top 10 genes significantly associated with Factor 12, tested using a linear model. The cell lines are ordered based on their values of Factor 12.</p></caption><graphic xlink:href="EMS199439-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>a</bold>: Variance explained in RNA and ATAC data modality by each factor. <bold>b</bold>: UMAP based on all factors coloured by cell type. <bold>c</bold>: UMAP of microglial cells coloured by Factor 14. <bold>d</bold>: UMAP of microglial cells colored by adolescence age group. <bold>e</bold>: Gene set overrepresentation analysis for the transcriptomics features with the highest absolute loadings of factor 14. The -log10 adjusted p-values are multiplied by the sign of the loadings to reflect the direction of the association with the factor. <bold>f</bold>: Gene set overrepresentation analysis for the ATAC features with the highest absolute loadings of factor 14. The -log10 adjusted p-values are multiplied by the sign of the loadings to reflect the direction of the association with the factor.</p></caption><graphic xlink:href="EMS199439-f004"/></fig></floats-group></article>